Finally, ODZ1 was involved with increased cell proliferation and invasion in glioblastoma (Talamillo et al., 2017) and was identified as a biomarker in papillary thyroid carcinoma (Cheng et al., 2017). This evidence concerns the gene TENM1 and differentiated thyroid carcinoma.